News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Election 2014, Local

Oberweis Comes Out for Same-Sex Marriage

Fresh
durbin oberweis

GOP challenger to Durbin insists this is not a change

in Local

Springfield Based Reporter Resigns Following Rauner Complaint

Chicago Sun Times

Dave McKinney was the Chicago Sun-Times' Springfield bureau chief.

in Local

Natural Gas Prices to Hold Steady This Winter

Ameren+Illinois+Utilities+logo

No wide price swings expected this winter

in Local

Elkhart Mine Expansion Vote Delayed

coal mine

Vote to extend waste site expected in November